Interestingly, intratumoral CD8+ T cells showed minimal expression of bile acid exporters, suggesting that reduction of bile acid efflux by tumor-reactive T cells further potentiates T cell dysfunction and lack of immunotherapy responsiveness in HCC treatment. The gene discussed is CD8A; the disease is hepatocellular carcinoma.